Skip to main content
Clinical Trials/ChiCTR2000039192
ChiCTR2000039192Active, not recruitingEarly Phase 1

骨科接台手术禁食禁饮方案优化对术后胰岛素抵抗的影响

自筹1 site in 1 country48 target enrollmentStarted: October 12, 2020Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
48
Locations
1
Primary Endpoint
血糖

Study Overview

Brief Summary

探究个体化缩短骨科接台手术术前禁饮禁食方案对患者术后胰岛素抵抗的影响。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
未说明

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 择期腰椎手术患者;年龄 18-79 岁;ASA 分级 I-III 级;签署知情同意书。

Exclusion Criteria

  • 糖尿病或糖耐量异常;服用影响胰岛素敏感性的药物;近 6 个月体重下降超过 10%;肿瘤患者 CT 提示存在远处转移;肾功能不全(肌酐>3mg/dl,透析);肝功能不全(Child-Pugh 分级 B 级或以上);胃食管返流;胃肠道梗阻或任何影响胃排空速度的状态。

Arms & Interventions

试验组

术前 2h 口服碳水化合物

对照组

传统禁食禁饮方法

Outcomes

Primary Outcomes

血糖

Time Frame: 术前和手术结束前

血胰岛素

Time Frame: 术前和手术结束前

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials